Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma

OBJECTIVE: We conducted a first‐in‐human study to evaluate the bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor (CAR) autologous T cells for treating recurrent anaplastic meningioma. METHODS: Tumor tissues from a patient with recurrent anaplastic meningioma were evaluated for B7‐H3...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Immunology
Main Authors: Tang, Xin, Liu, Fujun, Liu, Zhiyong, Cao, Yi, Zhang, Zongliang, Wang, Yuelong, Huang, Jianhan, Fan, Shuangming, Zhao, Shasha, Chen, Yaxin, Li, Gaowei, Wang, Shan, Zheng, Meijun, Hu, Yating, Li, Hongjian, Jiang, Caiying, Yang, Meijia, Yang, Hui, Xu, JianGuo, Guo, Gang, Tong, Aiping, Zhou, Liangxue
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7292833/
https://ncbi.nlm.nih.gov/pubmed/32547742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados